NCT06532253 - Long-term Safety Trial with NVDX3 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 22, 2024

Primary Completion Date

March 31, 2036

Study Completion Date

March 31, 2036

Conditions

Distal Radius FracturesDegenerative Lumbar Spondylolisthesis

Interventions

DRUG

NVDX3

NVDX3 is implanted during a single surgical intervention, that took place in the core trials (refer to NCT05961956 and NCT05987033)

Trial Locations (1)

RECRUITING

Centre Hospitalier de Luxembourg, Luxembourg